MPM Corporeos SA
BOVESPA:ESPA3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.88
1.63
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ESPA3 stock under the Base Case scenario is 2.38 BRL. Compared to the current market price of 1.09 BRL, MPM Corporeos SA is Undervalued by 54%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
MPM Corporeos SA
Run backtest to discover the historical profit from buying and selling ESPA3 based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
MPM Corporeos SA
Balance Sheet Decomposition
MPM Corporeos SA
Current Assets | 965.3m |
Cash & Short-Term Investments | 155.9m |
Receivables | 745m |
Other Current Assets | 64.4m |
Non-Current Assets | 1.3B |
Long-Term Investments | 22m |
PP&E | 379.5m |
Intangibles | 801.5m |
Other Non-Current Assets | 89.4m |
Current Liabilities | 550.9m |
Accounts Payable | 22.9m |
Accrued Liabilities | 69.9m |
Other Current Liabilities | 458.1m |
Non-Current Liabilities | 843.2m |
Long-Term Debt | 781.9m |
Other Non-Current Liabilities | 61.3m |
Earnings Waterfall
MPM Corporeos SA
Revenue
|
1B
BRL
|
Cost of Revenue
|
-645.5m
BRL
|
Gross Profit
|
367m
BRL
|
Operating Expenses
|
-233.5m
BRL
|
Operating Income
|
133.5m
BRL
|
Other Expenses
|
-157.6m
BRL
|
Net Income
|
-24m
BRL
|
Free Cash Flow Analysis
MPM Corporeos SA
BRL | |
Free Cash Flow | BRL |
ESPA3 Profitability Score
Profitability Due Diligence
MPM Corporeos SA's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
MPM Corporeos SA's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
ESPA3 Solvency Score
Solvency Due Diligence
MPM Corporeos SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
MPM Corporeos SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ESPA3 Price Targets Summary
MPM Corporeos SA
According to Wall Street analysts, the average 1-year price target for ESPA3 is 1.07 BRL with a low forecast of 1.06 BRL and a high forecast of 1.1 BRL.
Shareholder Yield
Current shareholder yield for ESPA3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
ESPA3 Price
MPM Corporeos SA
Average Annual Return | -73.34% |
Standard Deviation of Annual Returns | 14.84% |
Max Drawdown | -96% |
Market Capitalization | 394m BRL |
Shares Outstanding | 361 423 066 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
MPM Corpóreos SA engages in the provision of aesthetic services. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2021-02-01. The firm is mainly involved in laser hair removal sector, serving customers in owned and franchised stores in all Brazilian states under the Espacolaser brand and in Argentina under the Definit brand. Its offer is aimed at women and men and includes depilation of 35 and 29 areas of the body, respectively. In addition, through Estudioface brand, the Firm provides facial aesthetics services and treatments, such as botulinum toxin (botox) injections, other filling, laser facial treatments and peeling, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one ESPA3 stock under the Base Case scenario is 2.38 BRL.
Compared to the current market price of 1.09 BRL, MPM Corporeos SA is Undervalued by 54%.